Chiral Technologies, Inc. Announces the Promotion of Joseph Barendt to President


Posted May 31, 2016

WEST CHESTER, Pa. (May 31, 2016) —Chiral Technologies, Inc., part of Daicel Corporation, the global market leader in enantioselective chromatography is pleased to announce the promotion of Joseph M. Barendt, Ph.D. to the position of President. Dr. Barendt has been with the company for 10 years serving as Chief Operating Officer.

“In the 10 years since Joe joined Chiral Technologies, he has worked diligently to ensure the continued success of the company and our global offices. He has played a key role in consolidating our Global Marketing efforts and successfully launched the new Diffinity Genomics business unit,” stated Dieter Heckmann, Executive Officer, Daicel Corporation.

Dr. Barendt earned his Ph.D. in chemistry from the University of Colorado, and his MBA from the Joseph M. Katz School of Business at the University of Pittsburgh.

###

About Chiral Technologies

Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation.  Learn more at www.chiraltech.com and www.daicelchiraltech.cn.